ENTITY
WuXi AppTec

WuXi AppTec (2359 HK)

329
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
Refresh
bullishWuXi AppTec
20 Mar 2024 18:38Broker

WuXi AppTec (603259 CH) - Best Effort to Ensure Business Continuity

WuXi AppTec reported revenue of RMB40.3bn in 2023, up 2.5% YoY, attributable recurring net income of RMB9.7bn, up 16.8% YoY

Logo
174 Views
Share
bearishWuXi AppTec
20 Mar 2024 08:55

WuXi AppTec (2359.HK/603259.CH) 2023 Results - Time to Prepare for the Worst

WuXi AppTec’s 2023 results were disappointing. 2024 performance guidance is meaningless due to the increasingly intense geopolitical conflicts....

Logo
315 Views
Share
bearishWuXi AppTec
14 Mar 2024 09:16

WuXi AppTec (2359.HK/603259.CH) - Updates About the BIOSECURE Act and the Outlook

Based on latest news, the Biotechnology Industry Organization (BIO) would take "important steps" to support US national security and the BIOSECURE...

Logo
656 Views
Share
bearishWuXi AppTec
04 Mar 2024 11:33

Latest Impact of the US Biosecure Act on WuXi AppTec/WuXi Bio/WuXi XDC - China CXO Really Game Over?

Rally of WuXi AppTec/its subsidiaries is due to the news that Biden's order could reduce pressure on Democrats to support legislation targeting...

Logo
980 Views
Share
bearishWuXi AppTec
02 Feb 2024 14:56

WuXi AppTec (2359.HK/603259.CH) - Behind the Plunge Is a War

The plunge of WuXi AppTec and its subsidiaries are due to some negative progress of US Draft Bill - There're already 6 senators votes secured at...

Logo
683 Views
Share
x